Search Results
Sep 30, 2025, 17:23 ET Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)
actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date
More news about: Novartis Pharmaceuticals Corporation
Sep 29, 2025, 07:48 ET American Global Strategies Announces the addition of Ambassador Ed McMullen (Ret.) to the firm as a Senior Advisor
"Ambassador McMullen's addition to the firm will help AGS continue to provide unparalleled expertise to our clients across the defense, energy, technology, and pharmaceutical sectors," said Alexander Gray, CEO of AGS. "AGS is continuing to grow our team with highly skilled former senior officials
More news about: American Global Strategies
Sep 24, 2025, 08:16 ET American Global Strategies and Checkmate Government Relations Announce Strategic Partnership
WASHINGTON, Sept. 24, 2025 /PRNewswire/ -- Today, American Global Strategies LLC (AGS), a leading international advisory and consulting firm, announced their strategic partnership with Checkmate Government Relations, headed by Ches McDowell.
More news about: American Global Strategies
Sep 24, 2025, 02:45 ET New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies
actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date
More news about: Novartis Pharmaceuticals Corporation
Sep 02, 2025, 08:00 ET ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones
Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.
More news about: Carl Zeiss Meditec AG
Sep 02, 2025, 08:00 ET ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones
Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.
More news about: Carl Zeiss Meditec AG
Sep 01, 2025, 11:00 ET Regenerative Medicine Market is Estimated to Grow at a CAGR of 16% During 2025-2032 | SkyQuest Technology Consulting
landscape of the regenerative medicine market. In 2024, Novartis increased its holdings and contributed oncology-focused antibody expertise to MorphoSys AG's cell-and-gene platform by purchasing 91.04% of the company's shares. High-value discovery pipelines are offered by academic spin-offs, and mid-tier
More news about: SkyQuest Technology
Aug 26, 2025, 10:15 ET Surgical Microscopes Market worth US$2.69 billion by 2030 with 11.4% CAGR | MarketsandMarkets™
international presence supported by a robust distribution network and collaborations with leading clinicians. Since 2018, it has been part of Metall Zug AG's medical devices unit, enhancing its global reach in ophthalmic surgery and medical education. For more information,
More news about: MarketsandMarkets
Aug 26, 2025, 08:00 ET ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA
Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.
More news about: Carl Zeiss Meditec AG
Aug 26, 2025, 08:00 ET ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA
Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.
More news about: Carl Zeiss Meditec AG
Aug 21, 2025, 08:00 ET ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment
Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.
More news about: Carl Zeiss Meditec AG
Aug 21, 2025, 08:00 ET ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment
Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.
More news about: Carl Zeiss Meditec AG
Aug 20, 2025, 14:40 ET Artera Achieves FedRAMP High "In Process" Status to Support Federal Agencies
Artera Government Solutions (AGS), an Artera business unit, is the leading provider of patient communication technology to federal agencies, including the United States Department of Veterans Affairs, Department of Defense, and Indian Health Service sites. AGS builds on the 30-year legacy of AudioCARE,
More news about: Artera
Aug 11, 2025, 08:40 ET Take a Break and Refresh Your Collection at Morphy's Soda Pop, Advertising & General Store Auction, Aug. 18-20
This extremely desirable sign is expected to make $20,000-$40,000. The experts at AGS (Authentication & Grading Service) carefully examined a circa-1933 Coca-Cola double-sided porcelain sign with a Christmas bottle graphic and filigreed
More news about: Morphy Auctions
Aug 11, 2025, 01:20 ET Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren's disease
actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date
More news about: Novartis Pharmaceuticals Corporation
Aug 07, 2025, 08:39 ET Global Aerospace Tooling Distributor, US Air Tool Company, Achieves ISO 9001 Certification Through American Global Standards (AGS), Reinforcing Commitment to Quality and Operational Excellence
accredited by American Global Standards (AGS). This globally recognized standard affirms the company's commitment to quality management, customer satisfaction, and continuous operational improvement. The certification, awarded following a rigorous audit by AGS, validates USATCO's implementation of
More news about: US Air Tool Co., LLC
Aug 05, 2025, 16:05 ET Jazz Pharmaceuticals Announces Second Quarter 2025 Financial Results and Updates 2025 Financial Guidance
Xyrem net product sales were $35.3 million in 2Q25.Royalties from high-sodium oxybate AGs were $54.1 million in 2Q25.Epidiolex®/Epidyolex® (cannabidiol):
More news about: Jazz Pharmaceuticals plc
Aug 05, 2025, 16:05 ET Jazz Pharmaceuticals Announces Second Quarter 2025 Financial Results and Updates 2025 Financial Guidance
Xyrem net product sales were $35.3 million in 2Q25.Royalties from high-sodium oxybate AGs were $54.1 million in 2Q25.Epidiolex®/Epidyolex® (cannabidiol):
More news about: Jazz Pharmaceuticals plc
Aug 05, 2025, 07:00 ET Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025
2 2025: mainly related to the proposed divestiture of select assets of FME AG's wholly owned Spectra Laboratories as well as the proposed divestitures in Brazil, Kazakhstan and Malaysia as well as impairment losses primarily related
More news about: Fresenius Medical Care Holdings, Inc.
Aug 04, 2025, 20:00 ET Lightium, MPI Corporation, and Axiomatic_AI Announce Strategic Partnership to Revolutionize Photonic Integrated Circuit (PIC) Device Testing with AI-Driven Solutions
reasoning-based, artificial intelligence with MPI Corporation's industry-leading wafer probing systems and automation software, and leveraging Lightium AG's advanced testing infrastructure and deep expertise in ultra-high-speed photonic device measurements, the collaboration aims to bring fully integrated,
More news about: Lightium; MPI Corporation; Axiomatic_AI
Aug 04, 2025, 20:00 ET Lightium, MPI Corporation, and Axiomatic_AI Announce Strategic Partnership to Revolutionize Photonic Integrated Circuit (PIC) Device Testing with AI-Driven Solutions
reasoning-based, artificial intelligence with MPI Corporation's industry-leading wafer probing systems and automation software, and leveraging Lightium AG's advanced testing infrastructure and deep expertise in ultra-high-speed photonic device measurements, the collaboration aims to bring fully integrated,
More news about: Lightium; MPI Corporation; Axiomatic_AI
Aug 04, 2025, 08:30 ET Afaxys Secures $8 Million to Advance Mission and Accelerate Growth Strategy
family of companies that operate under three wholly owned subsidiaries: Afaxys Pharma, LLC, Afaxys Drug Development, LLC and Afaxys Group Services, LLC (AGS). Afaxys Pharma provides a broad portfolio of branded and generic contraceptives to the public healthcare market. Afaxys Drug Development provides development
More news about: Afaxys, Inc.
Aug 01, 2025, 01:44 ET ACKO Drive Brings Unbeatable Discounts on Maruti Suzuki Cars for July 2025
Dzire: Powertrains: Available with a 1.2-litre Z-series engine paired to either a 5-speed manual gearbox or a 5-speed AGS automatic. The AGS variant eliminates the need to use a clutch pedal when driving in stop-and-go traffic.Mileage: Delivers up to 24.79 km/litre
More news about: ACKO
Jul 31, 2025, 16:30 ET Novartis twice-yearly* Leqvio® (inclisiran) receives FDA approval for new indication enabling first-line use
actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date
More news about: Novartis Pharmaceuticals Corporation
Jul 31, 2025, 16:07 ET FAIR Calls on State AGs to Investigate and Enjoin Discriminatory 'Immigration Neutral' Prosecution Policies
multimedia:https://www.prnewswire.com/news-releases/fair-calls-on-state-ags-to-investigate-and-enjoin-discriminatory-immigration-neutral-prosecution-policies-302519101.html
More news about: Federation for American Immigration Reform (FAIR)